Literature DB >> 16477060

Nonpatentable drugs and the cost of our ignorance.

Frédéric Calon1.   

Abstract

Mesh：

Year:  2006        PMID： 16477060      PMCID： PMC1373754          DOI： 10.1503/cmaj.050663

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

1.  Time to put the Canadian Institutes of Health Research on trial.

Authors:  D L Sackett
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

2.  Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.

Authors:  J A Conquer; M C Tierney; J Zecevic; W J Bettger; R H Fisher
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

3.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study.

Authors:  Barbara Heude; Pierre Ducimetière; Claudine Berr
Journal:  Am J Clin Nutr       Date:  2003-04       Impact factor: 7.045

Review 4.  The high prevalence of inadequate serum vitamin D levels and implications for bone health.

Authors:  Jean-Yves Reginster
Journal:  Curr Med Res Opin       Date:  2005-04       Impact factor: 2.580

Review 5.  n-3 fatty acids and human health: defining strategies for public policy.

Authors:  A P Simopoulos
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 6.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors:  Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

7.  Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.

Authors:  Dianna H Wheaton; Dennis R Hoffman; Kirsten G Locke; Reginald B Watkins; David G Birch
Journal:  Arch Ophthalmol       Date:  2003-09

8.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Robert S Wilson; Neelum Aggarwal; Julie Schneider
Journal:  Arch Neurol       Date:  2003-07

9.  Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.

Authors:  A M Tully; H M Roche; R Doyle; C Fallon; I Bruce; B Lawlor; D Coakley; M J Gibney
Journal:  Br J Nutr       Date:  2003-04       Impact factor: 3.718

10.  Omega-3 fatty acids and risk of cognitive impairment and dementia.

Authors:  Danielle Laurin; René Verreault; Joan Lindsay; Eric Dewailly; Bruce J Holub
Journal:  J Alzheimers Dis       Date:  2003-08       Impact factor: 4.472
View more
  1 in total

Review 1.  Can Natural Products Exert Neuroprotection without Crossing the Blood-Brain Barrier?

Authors:  Manon Leclerc; Stéphanie Dudonné; Frédéric Calon
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.